Lipella Pharmaceuticals Unveils Advanced Bladder Imaging Technique at ICICJ Conference
Provided By GlobeNewswire
Last update: Aug 21, 2024
PITTSBURGH, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO), a clinical-stage biotech company, will highlight clinical data on LP-20, a novel MRI contrast agent designed for diagnosing interstitial cystitis and detecting bladder cancer at the 5th International Consultation on Interstitial Cystitis Japan (ICICJ) in Kyoto, Japan, taking place August 21-23, 2024.
Read more at globenewswire.com
